Shanghai Fochon Pharmaceutical Co., Ltd.

Chongqing Fochon Pharmaceutical Co., Ltd.

Fochon Pharmaceuticals, Ltd.

Fochon Pharma, Inc.

Chinese Academy of Sciences

Fochon Biosciences, Ltd.

Tongshuang Li

Weibo Wang

Xingdong Zhao

Xianlong Wang

Jing Sun

Yanxin Liu

Zuwen Zhou

Lihua Jiang

Ling Chen

Qihong Liu

Haohan Tan

Rui Tan

Zhifang Chen

Yue Rong

Qiang Tian

Zhifu Li

Lijun Yang

Fanxin Zeng

Weipeng Zhang

Min Lin

Huajie Zhang

Bin Liu

Li Linghu

Bo Fang

Chuiliang Yu

Quan Yuan

Hailong Shi

Jian Ding

Meiyu Geng

Hongbin Liu

Linghua Meng

Chengxi He

Zongyao Zou

Shu Lin

Yuwei Gao

Yunling Wang

Hong Fu

Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Macrocyclic compounds as TRK kinases inhibitors

Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Indolizine derivatives, composition and methods of use

Certain CDK4/6 inhibitors and pharmaceutically acceptable salts thereof are described. In particular, these compounds can inhibit kinase activity of CDK4/6 and may be useful for the treatment of hyper-proliferative diseases like cancer and inflammation. In addition, the pharmaceutical compositions thereof and methods of use thereof are also described.

Certain protein kinase inhibitors

Provided are certain CDK4/6 inhibitors with the structure of formula (I), pharmaceutical compositions thereof, and methods of use therefor. The compounds are of the class of pyrimidin-2 amine derivatives, useful for the treatment of hyper-proliferative diseases. 

Certain protein kinase inhibitor

Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof. 

Disclosed herein are protein kinase inhibitors, more particularly novel quinazoline derivatives and pharmaceutical compositions thereof, and method of use thereof.

Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Provided are certain dipeptidyl peptidase inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Certain dipeptidyl peptidase inhibitors

Growing community of inventors

Surrey, Canada

Tongshuang Li